DT Investment Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11
| Closed | -$3.03K | – | 557 |
|
|
2024
Q3 | $3.03K | Buy |
+11
| New | +$3.03K | ﹤0.01% | 573 |
|
|
2024
Q2 | – | Sell |
-5
| Closed | -$748 | – | 526 |
|
|
2024
Q1 | $748 | Hold |
5
| – | – | ﹤0.01% | 454 |
|
|
2023
Q4 | $901 | Hold |
5
| – | – | ﹤0.01% | 451 |
|
|
2023
Q3 | $886 | Hold |
5
| – | – | ﹤0.01% | 447 |
|
|
2023
Q2 | $946 | Hold |
5
| – | – | ﹤0.01% | 452 |
|
|
2023
Q1 | $1.01K | Hold |
5
| – | – | ﹤0.01% | 453 |
|
|
2022
Q4 | $1.19K | Hold |
5
| – | – | ﹤0.01% | 472 |
|
|
2022
Q3 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 446 |
|